Stocks to Watch: Richardson Electronics, Telomir, AZZ

Dow Jones10-09
 

By Kelly Cloonan

 

Richardson Electronics's profit soared in its latest quarter, driven by higher demand for its semiconductor wafer fabs. The company posted a profit of $1.9 million, up from $590,000 in the year-ago period. Revenue rose 1.6%, led by a 52% increase in semi-conductor wafer fab sales. The stock climbed 20% to $12.74 in after-hours trading.

Telomir Pharmaceuticals said its Telomir-1 compound showed it can kill aggressive triple-negative breast cancer cells in recent laboratory studies. As Telomir-1 concentrations increased, more cancer cells lost their ability to grow and survive. When iron was added back to the system, the cells recovered, showing the compound may selectively kill cancer cells while sparing healthy tissue, the company said. Shares gained 21% to $1.99 after market close.

AZZ logged higher profit and revenue in its latest quarter but the results came in below Wall Street's expectations. Adjusted earnings per share were $1.55, missing estimates of $1.57 a share according to analysts polled by FactSet. Revenue increased 2% to $417.3 million, driven by higher infrastructure-related spending in certain end markets. Analysts had modeled revenue of $426.6 million. The stock fell 7.2%, to $98.35, in late trading.

 

Write to Kelly Cloonan at kelly.cloonan@wsj.com

 

(END) Dow Jones Newswires

October 08, 2025 19:31 ET (23:31 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment